EUVIMEDEUVIMED entdecken
Open Access · CC BY 3.0

Are Selective Serotonin Reuptake Inhibitors a Secondary Cause of Low Bone Density?

Kim Chau, Stephanie A Atkinson, Valerie H Taylor

Journal of Osteoporosis · 2012

DOI: 10.1155/2012/323061 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Osteoporosis, 2012. Verfasst von Kim Chau und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Paediatrics, McMaster University, Hamilton, ON, Canada L8S 4L8. Die Arbeit wurde bisher 17-mal zitiert (Crossref) und nennt 44 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 3.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Osteoporosis is a chronic disease that can significantly impact numerous aspects of health and wellness. The individual consequences of osteoporosis can be devastating, often resulting in substantial loss of independence and sometimes death. One of the few illnesses with greater disease burden than low bone mineral density (BMD) is major depressive disorder (MDD). Both depression and antidepressant use have been identified as secondary causes of osteoporosis. The objective of this paper is to review and summarize the current findings on the relationship between antidepressant use and BMD.

Methods

Relevant sources were identified from the Pubmed and MEDLINE databases, citing articles from the first relevant publication to September 1st, 2010.

Results

2001 articles initially met the search criteria, and 35 studies were thoroughly reviewed for evidence of an association between SSRI use and BMD, and 8 clinical studies were detailed and summarized in this paper.

Conclusions

Current findings suggest a link between mental illness and osteoporosis that is of clinical relevance. Additional longitudinal studies and further research on possible mechanisms surrounding the association between SSRI use on bone metabolism need to be conducted. Treatment algorithms need to recognize this association to ensure that vulnerable populations are screened.

Autor:innen und Institutionen

  • Department of Paediatrics, McMaster University, Hamilton, ON, Canada L8S 4L8.

Zitieren

APA

Chau, K., Atkinson, S. A., & Taylor, V. H. (2012). Are Selective Serotonin Reuptake Inhibitors a Secondary Cause of Low Bone Density?. Journal of Osteoporosis. https://doi.org/10.1155/2012/323061

Vancouver

Chau K, Atkinson SA, Taylor VH. Are Selective Serotonin Reuptake Inhibitors a Secondary Cause of Low Bone Density?. Journal of Osteoporosis. 2012. doi:10.1155/2012/323061

BibTeX
@article{Chau2012,
  author = {Chau, Kim and Atkinson, Stephanie A and Taylor, Valerie H},
  title = {Are Selective Serotonin Reuptake Inhibitors a Secondary Cause of Low Bone Density?},
  journal = {Journal of Osteoporosis},
  year = {2012},
  doi = {10.1155/2012/323061}
}
Kostenlos starten →